This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Achalasia is a rare disorder of the esophagus, a muscular tube that connects the throat to the stomach. It is characterized by a muscular abnormality of the lower esophageal sphincter (LES) that prevents the esophagus from emptying correctly. As a result, food and liquid may remain in the esophagus and cause difficulty swallowing, chest pain, and regurgitation. The exact cause of achalasia is unknown, but it is thought to be due to a combination of genetic and environmental factors. Achalasia is typically diagnosed with an esophagogastroduodenoscopy (EGD) or barium swallow. An EGD is a test that uses a flexible tube with a camera on the end to examine the inside of the esophagus and stomach. A barium swallow is an X-ray test that uses a special contrast material to help visualize the esophagus. This test is helpful in determining the anatomy of the esophagus and the size of the LES. Treatment for achalasia may include medications, endoscopic treatments, or surgical procedures. Medications such as nitrates, calcium channel blockers, or botulinum toxin may be used to relax the LES muscles and make swallowing easier. Endoscopic treatments may include dilation of the LES with a balloon or injection of botulinum toxin into the LES. Surgery may be an option for people who do not respond to other treatments. Surgery involves cutting the LES, which can help improve swallowing and reduce symptoms. Achalasia is a rare and complex disorder that can cause difficulty swallowing and chest pain. Although its cause is unknown, it is important to diagnose and treat achalasia to prevent any further complications. Treatment usually involves medications, endoscopic treatments, or surgery.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States